Urolithiasis Risk Factors Following Extracorporeal Shock Wave Lithotripsy

  • Michael J. Nicar
  • R. Higgs
  • J. Seger
  • C. Fetner


A 24-hour urine collection was made in 43 randomly selected patients (11 female, 32 male), one to three months following extracorporeal shock wave lithotripsy (ESWL) with a Dornier HM3 lithotripter at Humana/Medical City Dallas. In order to better reveal metabolic abnormalities, each patient followed a restricted diet (low in calcium, sodium, and meat) and did not take medications which can affect the results of these studies.

The majority of patients (60%) had multiple risk factors. Low volume (51%) and hypocitraturia (49%) were most commonly observed. Hypercalciuria was present in 30% of cases. Elevated ammonia excretion, probably due to infection, was detected in 21%. A completely normal profile was found in 7%, with another 9% normal except for low volume, suggesting that no metabolic abnormalities were present in these patients. High, relative saturations of calcium oxalate and uric acid were observed in many cases but were generally normal, indicating that stone disease was rather modest in this group. These results imply that the majority of patients, following ESWL, present with abnormalities predisposing to recurrent stone formation; therefore, therapeutic intervention is required in order to prevent continued stone disease.


Uric Acid Calcium Oxalate Extracorporeal Shock Wave Lithotripsy Restricted Diet Relative Saturation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Pak CYC: Formation of renal stones may be prevented by restoring normal urinary composition. Proc EDTA 20: 371, 1983.Google Scholar
  2. 2.
    Preminger GM: Pharmacologic treatment of calcium calculi. Urol Clin N Am 14: 325, 1987.Google Scholar
  3. 3.
    Sarig S: The hyperuricosuric calcium oxalate stoneformer. Min Elect Metab 13: 251, 1987.Google Scholar
  4. 4.
    Finlayson B: Calcium stones: some physical and clinical aspects. In David DS (ed): Calcium Metabolism in Renal Failure and Nephrolithiasis. New York: Wiley and Sons, 1977.Google Scholar
  5. 5.
    Nicar MJ, Hsu MC, Johnson T, et al: The preservation of urine samples for determination of renal stone risk factors. Lab Med 18: 382, 1987.PubMedGoogle Scholar
  6. 6.
    Lemann J, Adams ND, Gray RW: Urinary calcium excretion in human beings. NEJM 301: 535, 1979.PubMedCrossRefGoogle Scholar
  7. 7.
    Strauss AL, Coe FL, Deutsch L, et al: Factors that predict relapse of calcium nephrolithiasis during treatment. Am J Med 72: 17, 1982.PubMedCrossRefGoogle Scholar
  8. 8.
    Nicar MJ, Hiu K, Pak CYC: Inhibition by citrate of spontaneous precipitation of calcium oxalate in vitro. J Bone Mineral Res 2: 215, 1987.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1988

Authors and Affiliations

  • Michael J. Nicar
    • 1
  • R. Higgs
    • 4
  • J. Seger
    • 2
  • C. Fetner
    • 3
  1. 1.Baylor University Medical CenterDallasUSA
  2. 2.Medical City DallasDallasUSA
  3. 3.Dallas Urology AssociatesDallasUSA
  4. 4.Texoma Urology CenterWichita FallsUSA

Personalised recommendations